Abstract
Tweetable abstractMepolizumab is a monoclonal antibody targeting IL-5, a cytokine and principal driver of disease in CRSwNP. We present the latest evi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
